Clinical Associate Professor
myeloma, Lymphoma, Aplastic anemia, Thrombocytopenia.
Autoimmune blood disease.
Benign and malignant blood diseases and
HSCT complications (GVHD, infection etc.)
Chinese Board of Internal Medicine
Visiting Fellow, M.D. Anderson Cancer Center (2011)
M.D., Peking University Health Science Center（2005）
Bachelor, Shandong Medical University
Clinical Associate Professor, HSCT Department, Lu Daopei Hospital (2005-present)
gold medal doctor by China Charity Federation in 2010
blood and marrow transplantation for advanced chronic myeloid leukemia
ZHAO Yan- li, WU Tong, ZHANG Yao-chen, CAOXing-yu , YIN
Yu-ming, WANG Jing-bo, ZHOU Jia-rui, SUN Rui-juan, LU Yue, ZHANG Jian-ping, JI
Shu-quan, LU Dao-pei.(2012).Haploidentical blood and marrow transplantation for
advanced chronic myeloid leukemia.Chinese Journal of Organ
Transplantation,33( 02 ): 73-76.
participated in editing books：
editing the second version “Leukemia therapeutics”, editing the chapter
of “Chronic myeloid leukemia”and “Hematopoietic stem cell transplantation in
chronic myelogenous leukemia”.
Making speech and wall
1、Haplotype hematopoietic stem cell transplantation
for advanced chronic myeloid leukemia， made speech and wall newspaper exchange In the
2008 Asia Pacific bone marrow transplant Conference (APBMT) and the 2009
European Blood Conference (EHA)
2、Sibling allogeneic hematopoietic stem cell
transplantation for 49 patients with chronic myelogenous leukemia，made speech at the fifth Chinese Conference on
3、Together infusion Semi identical bone marrow and
Non consanguineoustransplantation can reduce acute GVHD after transplantation，made speech and wall newspaper exchange In the
2010 Asia Pacific bone marrow transplant Conference (APBMT) and the2011
American bone marrow transplant annual meeting (ASBMT).
4、Chronic myeloid leukemia is similar to non sibling
allograft transplantation in the first chronic phase, made wall newspaper
exchange In the 2011 Asia Pacific bone marrow transplant Conference (APBMT)
5、Improved Outcomes of Haploidentical Blood and
Marrow Transplantation with GIAC-3 Protocol That Haploidentical Bone Marrow
from the Second Donor as the Third Party Cells, made wall newspaper
exchange In the 2014 American Society of Hematology Annual Meeting（ASH ）.
6、Haploidentical Hematopoietic Stem Cell
Transplantation after myeloablative conditioning for acute myeloid leukemia : A
Single-Center Study of 230 Cases ,made oral report in the 2014 Asia Pacific
bone marrow transplant Conference (APBMT) .
7、Improved Outcomes of Haploidentical Blood and
Marrow Transplantation in Hematologic Malignancies: A Single Center Study of
514 Cases. made wall newspaper exchange In the 2015 American Society of
Hematology Annual Meeting（ASH ）.